Sr One Capital Management, LP Arcellx, Inc. Transaction History
Sr One Capital Management, LP
- $269 Million
- Q4 2024
A detailed history of Sr One Capital Management, LP transactions in Arcellx, Inc. stock. As of the latest transaction made, Sr One Capital Management, LP holds 2,346,630 shares of ACLX stock, worth $166 Million. This represents 66.54% of its overall portfolio holdings.
Number of Shares
2,346,630
Previous 2,346,630
-0.0%
Holding current value
$166 Million
Previous $196 Million
8.8%
% of portfolio
66.54%
Previous 66.33%
Shares
4 transactions
Others Institutions Holding ACLX
# of Institutions
224Shares Held
45.1MCall Options Held
434KPut Options Held
433K-
Paradigm Biocapital Advisors LP New York, NY4.37MShares$309 Million12.7% of portfolio
-
Nea Management Company, LLC Timonium, MD3.75MShares$265 Million20.37% of portfolio
-
Black Rock Inc. New York, NY3.52MShares$249 Million0.0% of portfolio
-
Perceptive Advisors LLC New York, NY3.48MShares$246 Million8.84% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.33MShares$236 Million0.0% of portfolio
About Arcellx, Inc.
- Ticker ACLX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 43,819,200
- Market Cap $3.1B
- Description
- Arcellx, Inc., a clinical-stage biotechnology company, engages in the development of various immunotherapies for patients with cancer and other incurable diseases. The company's lead ddCAR product candidate is CART-ddBCMA, which is in phase 1 clinical trial for the treatment of patients with relapsed or refractory (r/r) multiple myeloma (MM). It...